Evidence map›Paper›PMID 9614223›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1998

Identification of four classes of brain nicotinic receptors using beta2 mutant mice.

M Zoli, C Léna, M R Picciotto, J P Changeux

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 387 citations in OpenAlex.

  1. Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.The international journal of neuropsychopharmacology · 2011
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.Cellular and molecular life sciences : CMLS · 2019
    Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

M ZoliCentre National de la Recherche Scientifique Unité de Recherche Associée D1284, Neurobiologie Moléculaire, Institut Pasteur, 75724 Paris Cédex 15, France.
C Léna
M R Picciotto
J P Changeux
Institut Pasteur · FR

Funding

Nicotine addiction in mice lacking the neuronal nAChRR01DA010455 · NIDA · YALE UNIVERSITY · PI PICCIOTTO, MARINA R · 2005 to 2009
$1.6M
NICOTINE ADDICTION IN MICE LACKING THE NEURONAL NACHRR29DA010455 · NIDA · YALE UNIVERSITY · PI PICCIOTTO, MARINA R. · 1996 to 2004
$612k
NIDA NIH HHS DA10455NIDA NIH HHS R01 DA010455NIDA NIH HHS R29 DA010455
6 · The paper itself

Abstract

Although the expression patterns of the neuronal nicotinic acetylcholine receptor (nAChR) subunits thus far described are known, the subunit composition of functional receptors in different brain areas is an ongoing question. Mice lacking the beta2 subunit of the nAChR were used for receptor autoradiography studies and patch-clamp recording in thin brain slices. Four distinct types of nAChRs were identified, expanding on an existing classification [Alkondon M, Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.], and tentatively identifying the subunit composition of nAChRs in different brain regions. Type 1 nAChRs bind alpha-bungarotoxin, are not altered in beta2 -/- mice, and contain the alpha7 subunit. Type 2 nAChRs contain the beta2 subunit because they are absent in beta2 -/- mice, bind all nicotinic agonists used with high affinity (excluding alpha-bungarotoxin), have an order of potency for nicotine >> cytisine in electrophysiological experiments, and are likely to be composed of alpha4 beta2 in most brain regions, with other alpha subunits contributing in specific areas. Type 3 nAChRs bind epibatidine with high affinity in equilibrium binding experiments and show that cytisine is as effective as nicotine in electrophysiological experiments; their distribution and persistence in beta2 -/- mice strongly suggest a subunit composition of alpha3 beta4. Type 4 nAChRs bind cytisine and epibatidine with high affinity in equilibrium binding experiments and persist in beta2 -/- mice; cytisine = nicotine in electrophysiological experiments. Type 4 nAChRs also exhibit faster desensitization than type 3 nAChRs at high doses of nicotine. Knock-out animals lacking individual alpha subunits should allow a further dissection of nAChR subclasses.

Indexed as

MutationAnimalsBrainBungarotoxinsElectrophysiologyLigandsMedulla OblongataMiceNeuronsPatch-Clamp TechniquesReceptors, NicotinicReference ValuesRNA, MessengerBungarotoxinsLigandsReceptors, NicotinicRNA, Messenger

Identifiers

PMID9614223
PMCPMC6792706
OpenAlexW1621382769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.